FDA Adverse Event Other Summary report: N

MEDPRO ACCUFLO WITH CHEMO INDICATION

MDR report key: 2270819 · Received September 26, 2011

Report

Report Number
3009089744-2011-00001
Event Type
Other
Date Received
September 26, 2011
Date of Event
March 1, 2011
Report Date
September 23, 2011
Manufacturer
B BRAUN MEDICAL PRODUCTION LTD
Product Code
MEB
PMA / PMN Number
K081905
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

FIELD RETURNED DEVICE FOR THE MEDPRO ELASTOMERIC INFUSION PUMPS OF 2.0 ML/HOUR SHOWED A HIGHER FLOW RATE WAS RECEIVED IN (B)(6) 2011, AND TESTED. TEST CONFIRMED THE DEVICE HAS A POTENTIAL FOR OVER-INFUSION. NO FIELD FAILURE DEVICE WAS RECEIVED FOR THE OTHER TWO INCIDENTS. MFR DECIDED TO RECALL THE CONCERNED LOTS. INCOMPLETE UV GLUE ADHESION AT THE GLASS TUBE AND PVC TUBE INTERFACES IN A SMALL PORTION OF ASSEMBLY RESULTED IN THE MALFUNCTION. TESTING OF RETENTION SAMPLES FROM THE LOTS AND OTHER LOTS SHOWED NO POTENTIAL FOR OVER-INFUSION - ALL TEST RESULTS SHOWED WITHIN SPEC PUBLISHED IN ISO 28620: 2010. MFR DECIDED TO TAKE THE CONSERVATIVE STAND AND RECALL NOT ONLY MEDICAL DEVICES WITH ALL LOT NUMBERS WITH CATALOG NUMBER CT-0020-240 MODEL, BUT ALL CATALOG NUMBER USING THE GLASS CAPILLARY CONFIGURATION IN EUROPE, THE UNITED STATES AND ALL COUNTRIES THESE LOT NUMBERS ARE SHIPPED TO. THE PURPOSE OF THE RECALL OF THESE LOT NUMBERS IS TO ELIMINATE THE RISK OF OVER-ADMINISTRATION OF DRUG SOLUTIONS AND TO ELIMINATE ANY RISK AND HARM TO THE PTS. ADD'L INFO: MODEL#: ACCURX, LOT#: 110401, CATALOG#: A20020-270C, EXP DATE: 03/2016. ADD'L MANUFACTURE DATE: 4/4/2011.

Description of Event or Problem · 1

BELOW ARE THE 3 EVENTS THAT WERE REPORTED BY MEDPRO'S EUROPEAN REP BETWEEN (B)(6) 2011. FIRST EVENT (IN (B)(6)) - THE DEVICE HAS BEEN USED ON (B)(6) FOR POST SURGICAL ANAESTHESIA FOR 24 HOURS ADMINISTRATION (FORESEEN) WITH FENTANIL (FENTANEST 5 FL). THE DEVICE HAS ADMINISTERED THE DRUG IN LESS THAN TWO HOURS. THE PT HAD LOSS OF CONSCIOUSNESS AND RESPIRATORY ARREST. IMMEDIATELY TREATED WITH NALOXONE. MFR INFORMED ON (B)(6) 2011 ((B)(6)LOCAL TIME). REPORTED TO NATIONAL COMPETENT AUTHORITY, (B)(6) HEALTH MINISTRY ON (B)(6) 2011 (CASE NO (B)(4)). SECOND EVENT (IN (B)(6)) - THE ACCUFLO PUMP WAS FILLED CORRECTLY WITH 5 FU 10,000 MG AND NACL 0.9% ON (B)(6) 2011 BY THE CUSTOMER (B)(6). THE PUMP WAS THEN ATTACHED ON THE SAME DAY AT 10:00 AM TO THE PT (B)(6). ON (B)(6), THE PT COMPLAINED OF NAUSEA, DIARRHEA AND VOMITING. THE PT WAS TO COME TO THE PHYSICIAN'S SURGERY (DR (B)(6)) IMMEDIATELY. THERE IT WAS ESTABLISHED AT 12:00 (HR) THAT THE ENTIRE 240 ML HAD ALREADY BEEN ADMINISTERED AFTER APPROX 26 HOURS ALTHOUGH THE ADMINISTRATION WAS TO TAKE 120 HOURS. THE GENERAL CONDITION OF THE PT WAS VERY POOR; HE WAS GIVEN 500 ML WITH CELLONDON 8 MG ON THE FIRST DAY TO DILUTE THE 5 FU. ON WEDNESDAY, HE WAS THEN GIVEN DEXAMETHASON 8 MG. ON THURSDAY, MR (B)(4) (AREA MGR OF MEDICAL (B)(4)) MET THE PT WHOSE GENERAL CONDITION HAS CLEARLY IMPROVED; HOWEVER HE RECEIVED A BLOOD TRANSFUSION THAT DAY NEVERTHELESS. WITH THE RESULT THAT THIS TIME THINGS STILL WENT WELL. NEITHER THE SURGERY NOR THE PT HAS INFORMED ANY MEDIA. PRODUCT USED WAS ACCUFLO ELASTOMERIC INFUSION PUMP SYS, MODEL NO: CT-0020-420, LOT NO: 90942. INFORMED TO MFR BY EUROPEAN REP ON (B)(4) 2011 (B)(4). EAR REPORTED TO (B)(4) ON (B)(4) 2011. (CASE NO (B)(4)). THIRD EVENT (IN (B)(6)) - THE INTENDED DOSE OF 5-FU (5000 MG/ML) EQUIVALENT 10000 MG FU ABSOLUTE, WAS AFTER CORRECT FILLING RELEASED INTO THE PT IN ABOUT 5H INSTEAD OF THE PLANNED 120H. CATALOG NO: CT-0020-240, LOT NO: 90942. THE CASE WAS REPORTED TO THE BFARM BY THE (B)(6). THE PT WAS ADMITTED TO THE (B)(6) HOSP. MFR INFORMED BY EUROPEAN REP ON (B)(4) 2011. EAR REPORTED TO (B)(4) ON (B)(4) 2011. (CASE NO (B)(4)).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MEDPRO ACCUFLO WITH CHEMO INDICATION PUMP, ELASTOMERIC INFUSION MEB B BRAUN MEDICAL PRODUCTION LTD ACCUFLO 110440

Patients

Seq Age Sex Outcome Treatment
1 NA